343 related articles for article (PubMed ID: 1612123)
21. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens.
Peretz T; Antebi SU; Beller U; Horowitz AT; Fuks Z; Vlodavsky I
Int J Cancer; 1990 Jun; 45(6):1054-60. PubMed ID: 2190937
[TBL] [Abstract][Full Text] [Related]
22. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.
Ishai-Michaeli R; Eldor A; Vlodavsky I
Cell Regul; 1990 Oct; 1(11):833-42. PubMed ID: 2088528
[TBL] [Abstract][Full Text] [Related]
23. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.
Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D
J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798
[TBL] [Abstract][Full Text] [Related]
24. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
26. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis.
Vlodavsky I; Fuks Z; Ishai-Michaeli R; Bashkin P; Levi E; Korner G; Bar-Shavit R; Klagsbrun M
J Cell Biochem; 1991 Feb; 45(2):167-76. PubMed ID: 1711529
[TBL] [Abstract][Full Text] [Related]
28. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts.
Goshen R; Hochberg AA; Korner G; Levy E; Ishai-Michaeli R; Elkin M; de Groot N; Vlodavsky I
Mol Hum Reprod; 1996 Sep; 2(9):679-84. PubMed ID: 9239682
[TBL] [Abstract][Full Text] [Related]
29. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.
Bar-Ner M; Eldor A; Wasserman L; Matzner Y; Cohen IR; Fuks Z; Vlodavsky I
Blood; 1987 Aug; 70(2):551-7. PubMed ID: 2955820
[TBL] [Abstract][Full Text] [Related]
31. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
32. Human platelet heparanase: purification, characterization and catalytic activity.
Freeman C; Parish CR
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
[TBL] [Abstract][Full Text] [Related]
33. A rapid quantitative assay for the detection of mammalian heparanase activity.
Freeman C; Parish CR
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):229-37. PubMed ID: 9224651
[TBL] [Abstract][Full Text] [Related]
34. Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone.
Pillarisetti S; Paka L; Sasaki A; Vanni-Reyes T; Yin B; Parthasarathy N; Wagner WD; Goldberg IJ
J Biol Chem; 1997 Jun; 272(25):15753-9. PubMed ID: 9188470
[TBL] [Abstract][Full Text] [Related]
35. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
37. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.
Goodall KJ; Poon IK; Phipps S; Hulett MD
PLoS One; 2014; 9(10):e109596. PubMed ID: 25295599
[TBL] [Abstract][Full Text] [Related]
38. Implications of heparan sulfate and heparanase in neuroinflammation.
Zhang X; Wang B; Li JP
Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
[TBL] [Abstract][Full Text] [Related]
39. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
40. Regulation of platelet heparanase during inflammation: role of pH and proteinases.
Ihrcke NS; Parker W; Reissner KJ; Platt JL
J Cell Physiol; 1998 Jun; 175(3):255-67. PubMed ID: 9572470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
